loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Pharmaceutical products - Abschluss eines nicht-exkl. Rabattvertrags nach § 130a Abs. 8 SGB V zu dem Wirkstoff Ustekinumab, ATC-Code: L04AC05 für die Zeit vom 1.6.2020 bis zum 31.5.2022

World Biggest Tenders Source

This tender with title Pharmaceutical products - Abschluss eines nicht-exkl. Rabattvertrags nach § 130a Abs. 8 SGB V zu dem Wirkstoff Ustekinumab, ATC-Code: L04AC05 für die Zeit vom 1.6.2020 bis zum 31.5.2022 has been published on Bidding Source portal dated 28 Apr 2020 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Pharmaceutical products - Abschluss eines nicht-exkl. Rabattvertrags nach § 130a Abs. 8 SGB V zu dem Wirkstoff Ustekinumab, ATC-Code: L04AC05 für die Zeit vom 1.6.2020 bis zum 31.5.2022
Invitation for Bids
2020/S 082-192966
Germany
Germany-Aachen
28 Apr 2020
4 Mar 2022
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

359051-Awarded - Germany – Pharmaceutical products – Minirin Parenteral 4µg Inj.lösung Germany 350661- Germany – Pharmaceutical products – 3. Biologics tender Germany 351177-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130c Paragraph 1 SGB V between IKK classic and Abacus Medicine A/S for Skyrizi(R) -- <b>Contract Value: 1,00 EUR</b> Germany 344615- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the option of concluding the agreement within the framework of the so-called open house procedure. Germany 349800- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130 a Paragraph 8 SGB V from 1 July 2025 Germany 336062- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-17 -Agalsidase beta Germany 330350- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V (SGB V) through an open-house model for the active ingredient fusidic acid/betamethasone (ATC code according to WHO: D07CC01) Germany 332579- Germany – Pharmaceutical products – Open House Original Discount Agreements 2025-17 - Beclometasone, Formoterol, Glycopyrronium (active ingredient combination) ATC: R03AL09 Germany 329876- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Vedolizumab, ATC L04AG05 for the period 01.07.2025 - 30.06.2027 Germany 332682- Germany – Pharmaceutical products – Open-house drug discount contracts pursuant to Section 130a, Paragraph 8c of the Social Code Book V for the KV region of Mecklenburg-Vorpommern Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans